Author

Anand D. Patel

Abterra Biosciences (United States)ORCID 0000-0001-6576-4579Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 2 Research Focus:benchmarking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Natalie E. Castellana· 2 shared Stefano R. BonissoneiD· 2 shared Geir Kjetil SandveiD· 1 shared Igor SnapkoviD· 1 shared Jan Terje AnderseniD· 1 shared Khang Lê QuýiD· 1 shared Konstantinos KalogeropoulosiD· 1 shared Maria ChernigovskayaiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Natalie E. Castellana

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases

Maria Chernigovskaya, Khang Lê Quý, Maria Stensland, Sachin Kumar Singh, Rowan Nelson, Melih Yilmaz, Konstantinos Kalogeropoulos, Pavel G. Sinitcyn, Anand D. Patel, Natalie E. Castellana, Stefano R. Bonissone, Stian Foss, Jan Terje Andersen, Geir Kjetil Sandve, Timothy P. Jenkins, , Victor Greiff

This study benchmarks mass spectrometry-based antibody sequencing methods, revealing biases related to sequence, concentration, protease, and bioinformatics tools.

Cell Systems · Nov 1, 2025Peer-reviewedImmunology

Serum proteomics reveals high-affinity and convergent antibodies by tracking SARS-CoV2 hybrid immunity to emerging variants of concern

Anand D. Patel, Thiago Lima, Richard Carson, Qiulong Huang, Stefano R. Bonissone, Natalie E. Castellana

The paper identifies high-affinity anti-SARS-CoV-2 antibodies in serum and B cells from donors with hybrid immunity, showing convergence and cross-reactivity against emerging variants.

Frontiers in Immunology · Feb 25, 2025Peer-reviewedImmunology